These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5897224)

  • 1. [Apropos of the current status of sensitivity of frequent pathogens of urinary tract infections to nitrofurantoin].
    Legler F
    Arzneimittelforschung; 1965 Mar; 15(3):299-300. PubMed ID: 5897224
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitrofurantoin: an effective and ignored antimicrobial.
    Arya SC; Agarwal N; Agarwal S
    Int J Antimicrob Agents; 2006 Apr; 27(4):354-5. PubMed ID: 16531014
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteriology of urinary tract infections and the effectiveness of antimicrobials against the urinary pathogens.
    Sengupta SR; Bansal MP; Deshpande PK; Sharma KD
    J Assoc Physicians India; 1972 Oct; 20(10):755-9. PubMed ID: 4570011
    [No Abstract]   [Full Text] [Related]  

  • 4. Can pregnant patients safely take nitrofurantoin?
    Koren G
    Can Fam Physician; 1996 Feb; 42():245-6. PubMed ID: 9222573
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibiotic and chemotherapy sensitivity of bacteria isolated from cases of urinary tract infections].
    Starzyk J; Hadzlik-Makarewicz H; Dolińska-Laskoś C
    Wiad Lek; 1985 Mar; 38(5):343-6. PubMed ID: 4013302
    [No Abstract]   [Full Text] [Related]  

  • 6. The sensitivity of urinary pathogens seen in a private pathological practice.
    Coombs ER; Judd GC; Loo D; Woods WE
    Med J Aust; 1976 Oct; 2(18):673-4. PubMed ID: 1012113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Cahen P; Honderlick P
    Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the in vitro sensitivity of Furadantin and Nalidixic acid (Wintomylon) on urinary pathogens.
    Bissessar R; Chen WN
    West Indian Med J; 1970 Mar; 19(1):48-53. PubMed ID: 5502005
    [No Abstract]   [Full Text] [Related]  

  • 9. [Variations in the in vitro reaction to some drugs of bacteria most commonly causing urinary tract infections in childhood].
    Principi N
    Minerva Pediatr; 1971 Mar; 23(13):586-91. PubMed ID: 5576859
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Dutch College of General Practitioners' guideline on urinary tract infections: response from the viewpoint of internal medicine].
    van den Broek PJ
    Ned Tijdschr Geneeskd; 2001 Apr; 145(15):718-20. PubMed ID: 11332252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of chemotherapeutic agents on the most common bacterial agents causing urinary infections].
    Lochmann O; Lochmannová J; Klimesová M; Nyc O
    Cesk Epidemiol Mikrobiol Imunol; 1993 Dec; 42(4):155-60. PubMed ID: 8306393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance.
    Kwon DH; Lee M; Kim JJ; Kim JG; El-Zaatari FA; Osato MS; Graham DY
    Antimicrob Agents Chemother; 2001 Jan; 45(1):306-8. PubMed ID: 11120984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance testing using the patch method on "dipslides"].
    Kolesar T; Nordgren S; Sahlin M
    Lakartidningen; 1973 Oct; 70(44):3909-10. PubMed ID: 4787897
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing dosing of nitrofurantoin from a PK/PD point of view: What do we need to know?
    Wijma RA; Fransen F; Muller AE; Mouton JW
    Drug Resist Updat; 2019 Mar; 43():1-9. PubMed ID: 30947111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrofurantoin.
    Med Lett Drugs Ther; 1971 Nov; 13(24):99-100. PubMed ID: 5163864
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional community-acquired urinary tract infections in Israel: diagnosis, pathogens, and antibiotic guidelines adherence: a prospective study.
    Nesher L; Novack V; Riesenberg K; Schlaeffer F
    Int J Infect Dis; 2007 May; 11(3):245-50. PubMed ID: 16891141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiorespirometric testing of antibiotic sensitivity in urinary tract infections: concise communication.
    Singh KT; Ganatra RD; Shah DH; Shanta M; Nimbkar YS; Gaitonde BB; Dudani RA; Jadav SK; Acharya VN
    J Nucl Med; 1980 Feb; 21(2):135-8. PubMed ID: 7356751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of ampicillin and other antimocrobial agents in non-tubercular urinary tract infections.
    Saxena H; Pratap VK; Agnihotri VS
    J Assoc Physicians India; 1972 May; 20(5):373-5. PubMed ID: 4655512
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of nitrofurantoin reduction by menthol leads to enhanced antimicrobial activity.
    Shahverdi AR; Fazeli MR; Rafii F; Kakavand M; Jamalifar H; Hamedi J
    J Chemother; 2003 Oct; 15(5):449-53. PubMed ID: 14598936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance of urinary isolates in the community and its relation to antibiotic use.
    Raz R; Hefter H; Oren B; Kennes Y; Potasman I
    Isr J Med Sci; 1993 Apr; 29(4):207-10. PubMed ID: 8491570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.